CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC (CELZ)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.11+4.72%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CELZ
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 |
| Total Revenues | — | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 |
| Cost of Revenues | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | — | — | — | — | — | — |
| Gross Profit | — | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | (0.0) | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 4.1 | 3.8 | 3.2 | 3.6 | 3.9 | 3.0 | 1.2 | 1.2 | — | — | — | — | — | — | — | — |
| R&D Expenses | 2.0 | 2.3 | 2.4 | 2.0 | 6.3 | 0.1 | 0.0 | 0.0 | 0.1 | 0.3 | 0.1 | — | — | — | — | — |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | — | — | (0.0) | (0.0) | (0.0) | — | — |
| Operating Income | (6.2) | (6.1) | (5.7) | (5.6) | (10.2) | (3.1) | (1.1) | (1.1) | (1.1) | (1.2) | (0.8) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | 0.0 | 4.3 | 1.2 | 1.9 | 1.4 | 0.4 | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 0.2 | 0.1 | 0.3 | 0.3 | 0.1 | 22.3 | (35.2) | (7.4) | (12.5) | (1.5) | — | — | — | — | — | (0.0) |
| EBT, Incl. Unusual Items | (6.0) | (6.0) | (5.5) | (5.3) | (10.1) | 19.2 | (36.3) | (8.5) | (13.7) | — | — | — | — | — | — | (0.0) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (6.0) | (6.0) | (5.5) | (5.3) | (10.1) | 19.2 | (36.3) | (8.5) | (13.7) | (2.7) | (0.8) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Per Share | ||||||||||||||||
| Basic EPS | — | — | — | — | (0.93) | 7.37 | (62.69) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (1.63) | (2.52) | (3.71) | (3.76) | (0.93) | 5.61 | (62.69) | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | — | — | — | — | 10.9 | 2.6 | 0.6 | — | — | — | — | 18.1 | 18.1 | 18.1 | — | — |
| Diluted Weighted Avg Shares | 3.7 | 2.4 | 1.5 | 1.4 | 10.9 | 3.2 | — | — | — | — | — | — | — | — | 18.1 | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | — | (5.7) | (5.6) | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | (6.2) | (6.1) | (5.7) | (5.6) | (10.2) | (3.1) | (1.1) | (1.1) | (1.1) | (1.2) | (0.8) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.